Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Rheumatology

Systemic Lupus (SLE)

Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis

Lupus | Jun 01, 2021 Systemic Lupus (SLE)

Efficacy, safety, and pharmacodynamic effects of the Bruton’s tyrosine kinase inhibitor, fenebrutinib (GDC-0853), in systemic lupus erythematosus

Arthritis & Rheumatology | Jun 01, 2021 Systemic Lupus (SLE)

Adherence to antimalarial therapy and risk of type 2 diabetes mellitus among patients with systemic lupus erythematosus: A population‐based study

Arthritis Care & Research | May 28, 2021 Systemic Lupus (SLE)

Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty

BMC Musculoskeletal Disorders | May 24, 2021 Systemic Lupus (SLE)

Findings and feasibility of major salivary gland ultrasound in childhood-onset systemic lupus erythematosus: A pilot study

Pediatric Rheumatology | May 21, 2021 Systemic Lupus (SLE)

Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus

Lupus | May 14, 2021 Systemic Lupus (SLE)

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Rheumatology | May 13, 2021 Systemic Lupus (SLE)

Performing a safe and effective total hip arthroplasty on patients with inactive or stably active systemic lupus erythematosus with osteonecrosis

Journal of the American Academy of Orthopedic Surgeons | May 13, 2021 Systemic Lupus (SLE)

Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus

Lupus | May 13, 2021 Systemic Lupus (SLE)

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet | May 12, 2021 Systemic Lupus (SLE)

« Prev 1 … 6 7 8 9 10 … 56 Next »

Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis

Efficacy, safety, and pharmacodynamic effects of the Bruton’s tyrosine kinase inhibitor, fenebrutinib (GDC-0853), in systemic lupus erythematosus

Adherence to antimalarial therapy and risk of type 2 diabetes mellitus among patients with systemic lupus erythematosus: A population‐based study

Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty

Findings and feasibility of major salivary gland ultrasound in childhood-onset systemic lupus erythematosus: A pilot study

Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Performing a safe and effective total hip arthroplasty on patients with inactive or stably active systemic lupus erythematosus with osteonecrosis

Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis

Efficacy, safety, and pharmacodynamic effects of the Bruton’s tyrosine kinase inhibitor, fenebrutinib (GDC-0853), in systemic lupus erythematosus

Adherence to antimalarial therapy and risk of type 2 diabetes mellitus among patients with systemic lupus erythematosus: A population‐based study

Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty

Findings and feasibility of major salivary gland ultrasound in childhood-onset systemic lupus erythematosus: A pilot study

Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Performing a safe and effective total hip arthroplasty on patients with inactive or stably active systemic lupus erythematosus with osteonecrosis

Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus

Efficacy and safety of voclosporin vs placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic